Cencora PharmaLex provides pharmaceutical and healthcare consulting services, focusing on regulatory affairs, product development, and quality management.

Cencora PharmaLex

LégiaPark is an economic activity center dedicated to hosting companies active in life sciences. It provides a suitable environment for research, production, or commercialization activities.

LégiaPark

PharmaLex is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives around the world

PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.

Learn more at http://www.pharmalex.com

PharmaLex

Unlock the future of personalized medicine with insights from Dr. Christian K Schneider in his latest article on targeted therapies!

Key takeaways include:
✅ The revolutionary impact of targeted medicines on patient outcomes.
✅  How biomarkers and companion diagnostics (CDx) connect life-saving therapies 
✅  The critical role of AI and machine learning in advancing precision medicine.
✅  Navigating regulatory pathways for successful approval and delivery.
✅  The importance of collaboration between developers, diagnostic teams, and regulators.

Explore the full article here: https://lnkd.in/dQhNng8V

#PharmaLex #TargetedMedicine #TargetedTherapies #Biomarkers #CompanionDiagnostics #RegulatoryAffairs #PharmaceuticalInnovation

What an incredible session at #JSM2024 in Portland discussing the regulatory acceptability of Bayesian methods! 

A huge shoutout to our team members Martina Fortin, Lauren Frazee, PhD, Brad Carlin and our brilliant speakers John Scott and Freda Cooner from FDA , Amy Xia from Amgen, Lauren Frazee, PhD from PharmaLex, and Ruitao Lin from MD Anderson Cancer Center.

The future of Bayesian methods in US and international regulatory science is truly promising!

Learn more about Statistics & Data Science at PharmaLex here: https://lnkd.in/gxRQJ48n

#BayesianMethods #RegulatoryScience #PharmaLex #DataScience

Automation, AI, and data analytics are transforming pharmaceutical outsourcing, bringing unprecedented agility, efficiency, and cost-effectiveness. Curious about how these innovations are shaping the future of drug development and commercialization?

Learn more in our latest blog post from Kirsten Jacobs, PhD, Chief Strategy Officer with PharmaLex: https://lnkd.in/dS-Qs_gc 

#PharmaLex #FutureofHealthcare #AI #Innovation

Stay informed of all the latest news, events, and thought leadership in the pharmaceutical, biotech and medical device industry!

Subscribe to our newsletter for exclusive industry insights about the rapidly-evolving #pharmaceutical industry ➡️ https://lnkd.in/ejiXKmbd

#Pharmalex #Newsletter

Join us tomorrow, August 6th, at 4:00 PM CET for our second Summer Shorts of our TMF Excellence Edition on the topic: "Risk-Based Quality Review: Inside Out". 

Our experts will guide you through managing and resolving conflicting directives. Learn how to navigate the complexities and find the right path for your organization.

⏰ Duration: 30 min

Secure your spot now: https://lnkd.in/dqTHKRmN

#PharmaLex #TMFExcellence #RiskBasedReview #ClinicalResearch #Webinar #SummerShorts Rob Jones

Happy to be at #JSM2024 in Portland with the other members of the Cencora-PharmaLex "dream team", Martina Fortin and Lauren Frazee, PhD! 

We're here for one more day; if you're in Portland, please stop by Booth 310 in the convention center Expo, say hello, and pick up some cool swag!

Metric
Company Name	Cencora PharmaLex	LégiaPark
Symbol
MSH ID	COM:PHARMALEX	BE:LEGIAPARK
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services
Industry	Pharmaceutical and Healthcare Consulting	Life Sciences
Country	DE	BE
Stage
Employee Count	1.66K
Website	pharmalex.com	legiapark.be
LinkedIn	cencorapharmalex	l%C3%A9giapark
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	10.52K
Web Traffic Growth	-0.16
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PHARMALEX

Cencora PharmaLex

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue